Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash Flows from Operating Activities:
Net income	$ 589,879	$ 141,281
Adjustments to reconcile net income to net cash used in operating activities:
Stock-based compensation expense to certain officers and directors		207,087
Interest earned on marketable securities held in Trust Account	(1,930,770)	(798,002)
Unrealized loss on marketable securities held in Trust Account	(5,531)	81,626
Benefit from income taxes		(17,142)
Deferred benefit from income taxes	(202,156)
Changes in operating assets and liabilities:
Prepaid expenses	11,761	(168,663)
Prepaid insurance	25,681	(79,431)
Accrued expenses	563,894	135,347
Income taxes payable	587,779	146,559
Net cash used in operating activities	(359,463)	(351,338)
Cash Flows from Investing Activities:
Cash withdrawn from Trust Account to pay franchise taxes	214,995
Investment of cash into Trust Account		(70,380,000)
Extension deposit into Trust Account	(1,380,000)
Net cash used in investing activities	(1,165,005)	(70,380,000)
Cash Flows from Financing Activities:
Proceeds from sale of units, net of underwriting discounts paid		67,965,000
Proceeds from sale of private placement units		3,945,000
Proceeds from promissory note - related party	1,380,000	100,085
Payment of offering costs	(75,000)	(581,635)
Net cash provided by financing activities	1,305,000	71,428,450
Net Change in Cash and Restricted Cash	(219,468)	697,112
Cash and Restricted Cash – Beginning of period	607,816	34,393
Cash and Restricted Cash – End of period	388,348	731,505
Cash and Restricted Cash, end of period
Cash	326,280	731,505
Cash – restricted	62,068
Cash and Restricted Cash, end of period	388,348	731,505
Non-Cash investing and financing activities:
Offering costs included in accrued offering costs		75,000
Remeasurement of carrying value to redemption value	2,838,674	6,394,188
Deferred underwriting fee payable		$ 2,070,000